De novo Minimal Change Disease in an Adolescent after Pfizer-BioNTech COVID-19 Vaccination: A Case Report

This is the first report in an adolescent of minimal change disease (MCD) after the first injection of the BNT162b2 COVID-19 vaccine (Pfizer-BioNTech) with complete remission following steroid treatment. An 18-year-old white male with no prior medical history complained of gastrointestinal symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Pella, Eva, Sarafidis, Pantelis A., Alexandrou, Maria-Eleni, Stangou, Maria, Nikolaidou, Christina, Kosmidis, Dimitrios, Papagianni, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082176/
https://www.ncbi.nlm.nih.gov/pubmed/35611026
http://dx.doi.org/10.1159/000521981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082176/
https://www.ncbi.nlm.nih.gov/pubmed/35611026
http://dx.doi.org/10.1159/000521981

Ejemplares similares